^
BIOMARKER:

MLL3 mutation + TMB-H

i
Other names: MLL3, KMT2C, Lysine Methyltransferase 2C, Histone-Lysine N-Methyltransferase 2C, Myeloid/Lymphoid Or Mixed-Lineage Leukemia Protein 3, Lysine (K)-Specific Methyltransferase 2C, Histone-Lysine N-Methyltransferase, H3 Lysine-4 Specific, Myeloid/Lymphoid Or Mixed-Lineage Leukemia 3, Histone-Lysine N-Methyltransferase MLL3, Lysine N-Methyltransferase 2C, ALR-Like Protein, KLEFS2, TMB | Tumor Mutational Burde
Entrez ID:
Related biomarkers:
News
Twitter
Trials
MLL3 mutation + TMB-H
NSCLC
PD1 inhibitor + CTLA4 inhibitor
Sensitive: B - Late Trials
MLL3 mutation + TMB-H
NSCLC
PD-L1 inhibitor
Sensitive: B - Late Trials
MLL3 mutation + TMB-H
CRC
Immunotherapy
Sensitive: C3 – Early Trials